Works matching IS 0008543X AND DT 2023 AND VI 129 AND IP 7
Results: 21
PSA testing in older men adds unnecessary expenditures to Medicare Advantage plans.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 980, doi. 10.1002/cncr.34720
- By:
- Publication type:
- Article
Balancing the benefits and harms of cervical cancer screening in older women.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 979, doi. 10.1002/cncr.34719
- By:
- Publication type:
- Article
First person profile: Yi‐Long Wu, MD: Dr Wu's research has progressed from improving the survival rates of patients with non–small cell lung cancer and is now focused on ensuring that he and the next generation of researchers can find a cure.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 978, doi. 10.1002/cncr.34695
- By:
- Publication type:
- Article
Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2– metastatic breast cancer in the United States: A SEER‐Medicare population‐based study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1051, doi. 10.1002/cncr.34675
- By:
- Publication type:
- Article
A phase 1 dose‐escalation study of the poly(ADP‐ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1041, doi. 10.1002/cncr.34662
- By:
- Publication type:
- Article
What's the reality for CDK4/6 inhibitors: Clinical trials or real‐world evidence?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 986, doi. 10.1002/cncr.34672
- By:
- Publication type:
- Article
Reply to "Is there a role for combined anti–PD‐1/CTLA‐4 checkpoint blockade in the management of advanced biliary tract cancers?".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1131, doi. 10.1002/cncr.34659
- By:
- Publication type:
- Article
Is there a role for combined anti–PD‐1/CTLA‐4 checkpoint blockade in the management of advanced biliary tract cancers?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1129, doi. 10.1002/cncr.34660
- By:
- Publication type:
- Article
Preventable harm because of outpatient medication errors among children with leukemia and lymphoma: A multisite longitudinal assessment.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1064, doi. 10.1002/cncr.34651
- By:
- Publication type:
- Article
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1075, doi. 10.1002/cncr.34645
- By:
- Publication type:
- Article
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1085, doi. 10.1002/cncr.34643
- By:
- Publication type:
- Article
Building new standards to prevent harm from medication errors in children with cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 989, doi. 10.1002/cncr.34650
- By:
- Publication type:
- Article
Association of polypharmacy and potential drug‐drug interactions with adverse treatment outcomes in older adults with advanced cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1096, doi. 10.1002/cncr.34642
- By:
- Publication type:
- Article
The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1005, doi. 10.1002/cncr.34641
- By:
- Publication type:
- Article
The impact of mindfulness on cancer‐related cognitive impairment in breast cancer survivors with cognitive complaints.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1105, doi. 10.1002/cncr.34640
- By:
- Publication type:
- Article
A novel prognostic system combining carbonic anhydrase II and preoperative CA19‐9 for intrahepatic cholangiocarcinoma after curative resection.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1030, doi. 10.1002/cncr.34639
- By:
- Publication type:
- Article
Emotional, behavioral, and physical health consequences of loneliness in young adult survivors of childhood cancer: Results from the Childhood Cancer Survivor Study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1117, doi. 10.1002/cncr.34633
- By:
- Publication type:
- Article
AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 992, doi. 10.1002/cncr.34608
- By:
- Publication type:
- Article
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1017, doi. 10.1002/cncr.34609
- By:
- Publication type:
- Article
Top advances of the year: Leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 981, doi. 10.1002/cncr.34619
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 971, doi. 10.1002/cncr.33705
- Publication type:
- Article